SANDALOVA, Sofya. Early Post-Marketing Safety Profile of Fezolinetant in FAERS: A Disproportionality Analysis With Emphasis on Hepatotoxicity. International Journal of Medical Students, [S. l.], 2026. Disponível em: https://ijms.info/IJMS/article/view/4780. Acesso em: 28 aug. 2026.